Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Retained Earnings	Accumulated Other Comprehensive Loss
Balance as of the beginning of the fiscal period at Oct. 31, 2019	$ 859,578	$ 106,742	$ 784,885	$ (32,049)
Increase (Decrease) in Stockholders' Equity
Cash dividends paid on common stock	(107,698)		(107,698)
Issuance of shares for exercised stock options and vested restricted stock units and performance shares awards	19,630	870	18,760
Stock-based compensation expense	15,408		15,408
Contribution of stock to a deferred compensation trust	2,568		2,568
Purchase of shares of common stock	(2,146)	(29)	(2,117)
Other comprehensive loss	(2,213)			(2,213)
Net earnings	329,701		329,701
Balance as if the end of the fiscal period at Oct. 31, 2020	1,114,828	107,583	1,041,507	(34,262)
Increase (Decrease) in Stockholders' Equity
Cash dividends paid on common stock	(112,440)		(112,440)
Issuance of shares for exercised stock options and vested restricted stock units and performance shares awards	11,615	611	11,004
Stock-based compensation expense	21,809		21,809
Contribution of stock to a deferred compensation trust	1,485	23	1,462
Purchase of shares of common stock	(304,311)	(3,011)	(301,300)
Other comprehensive loss	8,266			8,266
Net earnings	409,880		409,880
Balance as if the end of the fiscal period at Oct. 31, 2021	1,151,132	105,206	1,071,922	(25,996)
Increase (Decrease) in Stockholders' Equity
Cash dividends paid on common stock	(125,709)		(125,709)
Issuance of shares for exercised stock options and vested restricted stock units and performance shares awards	10,372	349	10,023
Stock-based compensation expense	22,116		22,116
Contribution of stock to a deferred compensation trust	(33)	(33)
Purchase of shares of common stock	(142,390)	(1,552)	(140,838)
Other comprehensive loss	(7,129)			(7,129)
Net earnings	443,342		443,342
Balance as if the end of the fiscal period at Oct. 31, 2022	$ 1,351,701	$ 103,970	$ 1,280,856	$ (33,125)